Overview Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED) Status: Completed Trial end date: 2007-11-01 Target enrollment: Participant gender: Summary This study will evaluate the comparative bioavailability of three capsule formulations of MK-0974. Phase: Phase 1 Details Lead Sponsor: Merck Sharp & Dohme Corp.